Extension of Medicare immunosuppressive drug benefits: a "no brainer" that did not happen.
Bennett
William M
WM
D016527:Drug Costs; D004608:Eligibility Determination; D033161:Government Regulation; D018166:Health Care Reform; D006297:Health Services Accessibility / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics / Q000627:therapeutic use*; D007342:Insurance Benefits / Q000191:economics / Q000331:legislation & jurisprudence; D019458:Insurance Coverage; D007349:Insurance, Health, Reimbursement; D007676:Kidney Failure, Chronic / Q000191:economics / Q000628:therapy*; D016030:Kidney Transplantation / Q000191:economics / Q000331:legislation & jurisprudence; D006278:Medicare / Q000191:economics / Q000331:legislation & jurisprudence; D006435:Renal Dialysis / Q000191:economics; D014481:United States
D007166:Immunosuppressive Agents